Lilly 1Q Revenues: $5.9 billion (+15%) 1Q Earnings: $1.5 billion (-66%) Comments: Trulicity sales were up 40% to $1.2 billion driven by increased volume, partially offset by lower realized prices. Humalog sales were $695.8 million, down 5% driven primarily by lower realized prices due to changes in estimates for rebates and discounts and changes in segment mix, partially offset by increased volume. Alimta sales were $560.1million, up 12% primarily driven by increased volume. Talz sal...